Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Patient-Reported Health-Related Quality of Life Impact and Symptom Severity in Patients with Lyme Borreliosis in the Burden of Lyme Disease (BOLD) Study
Pfizer Inc, HTA Value & Evidence, Collegeville, PA 19426 USA..
Pfizer Inc, HTA Value & Evidence, New York, NY 10001 USA..
Pfizer Res & Dev, Tadworth KT20 7NS, Surrey, England..
Pfizer Corp Austria GmbH, Pfizer Res & Dev, A-1210 Vienna, Austria..
Vise andre og tillknytning
2026 (engelsk)Inngår i: Pathogens, E-ISSN 2076-0817, Vol. 15, nr 7, artikkel-id 701Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Lyme borreliosis (LB) can manifest as a localized infection or, if left untreated, disseminated disease. This analysis used Patient-Reported Outcome tools to assess general health, fatigue, pain, and cognitive function in patients with localized or disseminated LB, compared with age- and site-matched controls without LB. All participants were enrolled in the Burden of Lyme Disease (BOLD) study; LB cases were assessed at 3 time points: the enrollment visit, and two follow-up visits conducted within 10 months of enrollment. Controls were evaluated at 2 time points: the enrollment contact and a follow-up contact 16-18 months post-enrollment. Symptom severity and general health quality between groups were compared using two-tailed Student's t-tests and multivariate regression analyses. Disseminated LB cases reported greater fatigue and pain than localized LB (disseminated LB fatigue scores: 4.1, 3.7, and 3.5 at Visits 1, 2, and 3, respectively vs. localized LB: 2.9, 3.0, and 2.9; disseminated LB pain scores: 2.5, 1.6, and 1.3 vs. localized LB: 0.9, 0.6, and 0.8) and controls (fatigue score: 3.2; pain score: 1.0). Disseminated LB was also associated with reduced health-related quality of life. The results of this study indicate that health-related quality of life may vary by disease stage and that patients with disseminated disease showed persistent impairment during the acute phase and at 10-month follow-up.

sted, utgiver, år, opplag, sider
MDPI, 2026. Vol. 15, nr 7, artikkel-id 701
Emneord [en]
Lyme borreliosis, Lyme disease, localized LB, disseminated LB, patient-reported outcomes, quality of life
HSV kategori
Identifikatorer
URN: urn:nbn:se:bth-30393DOI: 10.3390/pathogens15070701ISI: 001831875000001PubMedID: 42515028Scopus ID: 2-s2.0-105046175997OAI: oai:DiVA.org:bth-30393DiVA, id: diva2:2092062
Forskningsfinansiär
Pfizer ABTilgjengelig fra: 2026-08-13 Laget: 2026-08-13 Sist oppdatert: 2026-08-17bibliografisk kontrollert

Open Access i DiVA

fulltext(988 kB)27 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 988 kBChecksum SHA-512
1b6a65477ec2b2dcb34e7b58293ab94e72ccbea57806eddbcb66ca663a3a4aa7cd91ca4baf2e85a80a2c6e8dfecd92d555fe106b3b013fd16ef7cbcde6c212de
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Sanmartin Berglund, Johan

Søk i DiVA

Av forfatter/redaktør
Sanmartin Berglund, Johan
Av organisasjonen
I samme tidsskrift
Pathogens

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 27 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 2330 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf